Related Experiment Video
Updated: Jul 24, 2025

12:41
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
4.9K
Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data
C Wu1, E B Gunnarsson2, E M Myklebust3
1Department of Industrial and Systems Engineering, University of Minnesota, Twin Cities, MN 55455, USA.
Arxiv
|July 3, 2023
Summary
Tumor heterogeneity poses challenges for cancer therapy. A new stochastic model improves analysis of drug-response subpopulations from screening data, offering more robust estimations and better treatment strategies.
Area of Science:
- Computational biology
- Cancer research
- Systems biology
Background:
- Tumor heterogeneity, characterized by distinct subpopulations, complicates effective cancer therapy development.
- Accurate characterization of subpopulation structure is crucial for precise treatment strategies.
- Previous computational frameworks like PhenoPop used deterministic models, limiting their analytical power.
Approach:
- Developed a novel stochastic model based on the linear birth-death process to analyze tumor heterogeneity.
- The model incorporates dynamic variance, enhancing data utilization and estimation robustness.
- The stochastic model accommodates experimental data with positive time correlation.
Key Points:
- The stochastic model offers improved model fit and information extraction compared to deterministic approaches.
- It provides more robust estimations by formulating dynamic variance over the experimental horizon.
- The model's adaptability to time-correlated data enhances its applicability.
Conclusions:
- The proposed stochastic model advances the analysis of tumor heterogeneity from drug screening data.
- This approach enables more precise characterization of drug-response subpopulations.
- The model demonstrates advantages in both simulated and experimental data analyses, supporting its utility in cancer research.

